Paper145246
Thymidylate synthetase - a target enzyme in cancer chemotherapy.
Danenberg PV. Biochim Biophys Acta, 1977. Cited by 539 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Thymidylate synthetase - a target enzyme in cancer chemotherapy. Papers, record 145246. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/145246
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Deoxyuracil Nucleotides | Major topic |
| Methyltransferases | Major topic |
| Neoplasms | Major topic |
| Thymidylate Synthase | Major topic |
| Animals | |
| Binding, Competitive | |
| Cysteine | |
| DNA, Neoplasm | |
| Female | |
| Floxuridine | |
| Humans | |
| In Vitro Techniques | |
| Iodoacetamide | |
| Kinetics | |
| Male | |
| Models, Chemical | |
| Tetrahydrofolates | |
| Thionucleotides | |
| Thymine Nucleotides |
Source PubMed
Cited by142
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 539 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,830,607 | Triazole-Linked Pyrimidine Nucleoside Dimers: Design, Synthesis, and Applications in Medicinal and Nucleic Acid Chemistry. Part IV. | Chem Biol Drug Des | 2026 | https://conductscience.org/library/papers/42830607 | PubMed |
| 39,688,409 | Repurposing zidovudine and 5-fluoro-2'-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity-reducing agent uridine. | J Antimicrob Chemother | 2025 | https://conductscience.org/library/papers/39688409 | PubMed |
| 38,467,988 | Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil. | Dermatol Ther (Heidelb) | 2024 | https://conductscience.org/library/papers/38467988 | PubMed |
| 37,588,189 | Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake. | Genes Dis | 2024 | https://conductscience.org/library/papers/37588189 | PubMed |
| 37,147,729 | Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers. | Biomark Res | 2023 | https://conductscience.org/library/papers/37147729 | PubMed |
| 37,000,221 | The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent. | Cancer Chemother Pharmacol | 2023 | https://conductscience.org/library/papers/37000221 | PubMed |
| 36,643,896 | Regulation of 5-fluorodeoxyuridine monophosphate-thymidylate synthase ternary complex levels by autophagy confers resistance to 5-fluorouracil. | FASEB Bioadv | 2023 | https://conductscience.org/library/papers/36643896 | PubMed |
| 35,163,122 | Antibody Conjugated PLGA Nanocarriers and Superparmagnetic Nanoparticles for Targeted Delivery of Oxaliplatin to Cells from Colorectal Carcinoma. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163122 | PubMed |
| 34,650,802 | Thymidylate synthase locus LOH in combination with genotype has prognostic and predictive significance in colorectal cancer. | Mol Clin Oncol | 2021 | https://conductscience.org/library/papers/34650802 | PubMed |
| 34,646,134 | Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34646134 | PubMed |
| 34,336,653 | Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy. | Front Oncol | 2021 | https://conductscience.org/library/papers/34336653 | PubMed |
| 33,285,053 | Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer. | Cancer Res Treat | 2021 | https://conductscience.org/library/papers/33285053 | PubMed |
| 32,439,610 | Reprogramming of serine, glycine and one-carbon metabolism in cancer. | Biochim Biophys Acta Mol Basis Dis | 2020 | https://conductscience.org/library/papers/32439610 | PubMed |
| 31,778,273 | Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy. | Cancer Sci | 2020 | https://conductscience.org/library/papers/31778273 | PubMed |
| 31,653,009 | Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31653009 | PubMed |
| 31,609,087 | A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model. | Cancer Med | 2019 | https://conductscience.org/library/papers/31609087 | PubMed |
| 31,434,972 | Predictive and Prognostic Value of 18F-fluorodeoxyglucose Uptake Combined with Thymidylate Synthase Expression in Patients with Advanced Non-Small Cell Lung Cancer. | Sci Rep | 2019 | https://conductscience.org/library/papers/31434972 | PubMed |
| 30,668,271 | Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil. | J Glob Oncol | 2019 | https://conductscience.org/library/papers/30668271 | PubMed |
| 30,521,565 | An efficient proteome-wide strategy for discovery and characterization of cellular nucleotide-protein interactions. | PLoS One | 2018 | https://conductscience.org/library/papers/30521565 | PubMed |
| 30,200,215 | Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30200215 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TYMS | 7,298 | PubTator's text mining | https://conductscience.org/library/genes/7298 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/145246
GET https://conductscience.org/api/papers/v1/145246/cited_by?page=2